Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 1/2004

01-01-2004 | Case Report

Skeletal tuberculosis mimicking seronegative spondyloarthropathy

Authors: Mohammed Hammoudeh, Izzat Khanjar

Published in: Rheumatology International | Issue 1/2004

Login to get access

Abstract

Skeletal tuberculosis (TB) is still a common problem in developing countries. It is a postprimary manifestation of TB and appears usually with fever, pain, tenderness, and limitation of motion at the involved site. We present a patient with a clinical course very suggestive of seronegative spondyloarthropathy and who had partially responded to sulphasalazine (SSZ) and nonsteroidal anti-inflammatory drugs (NSAID) but proved later to be a TB case.
Literature
1.
Ridley N, Shaish MI, Remedies D, Mitchell R (1998) Radiology of skeletal tuberculosis. Orthopedics 21:1213–1220PubMed
2.
Auge B, Toussirot E, Wendling D (1999) Tuberculous rheumatism presenting as spondyloarthropathy. J Rheumatol 26:2288–2289PubMed
3.
Williams KD (1998) Tuberculosis and unusual infections. In: Canale ST (ed) Campbell's operative orthopedics, 9th edn. Mosby, St. Louis, pp 626–67
4.
Gonzalez-Gay MA, Garcia-Prua C, Cereijo MJ et al (1999) The clinical spectrum of osteoarticular tuberculosis in a defined area of northwestern Spain (1988–1997). Clin Exp Rheumatol 17:663–669PubMed
5.
Thijn CJP, Steensma JT (1990) Epidemiology of bone and joint tuberculosis. In: Thijn CJP, Steensma JT (eds) Tuberculosis of the skeleton. Springer, Berlin Heidelberg, pp 11–12
6.
Abded Wahed IF, Kenan S, Hermann G et al (1993) Tuberculous peroneal tenosynovitis. J Bone Joint Surg Am 75 No.11:1687–1690
7.
Douglas M, Van Der Linden S, Juhlin R et al (1991) The European Study Group preliminary criteria for classification of spondyloarthropathy. Arthritis Rheum :1218–1227
Metadata
Title
Skeletal tuberculosis mimicking seronegative spondyloarthropathy
Authors
Mohammed Hammoudeh
Izzat Khanjar
Publication date
01-01-2004
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 1/2004
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-003-0334-z

Other articles of this Issue 1/2004

Rheumatology International 1/2004 Go to the issue

Original Article

Expression of fibronectin splice variants and oncofetal glycosylated fibronectin in the synovial membranes of patients with rheumatoid arthritis and osteoarthritis

Original Article

Anemia, serum vitamin B12, and folic acid in patients with rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus

Case Report

Unstable pelvic insufficiency fracture in a patient with rheumatoid arthritis

Original Article

Production of adrenomedullin from synovial cells in rheumatoid arthritis patients

Letter to the Editor

Functional disability and quality of life in patients with ankylosing spondylitis

Comment

Functional disability and quality of life in patients with ankylosing spondylitis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits